This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Molecular karyotyping and gene expression analysis in childhood cancer patients
Journal of Molecular Medicine Open Access 23 June 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Brown JR, Neuberg D, Phillips K, Reynolds H, Silverstein J, Clark JC et al. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders. Br J Haematol 2008; 143: 361–368.
Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Nat Acad Sci USA 2007; 104: 20007–20012.
Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK et al. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. Br J Haematol 2010; 151: 336–345.
Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002; 100: 2289–2290.
Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28–40.
Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L et al. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010; 115: 3916–3922.
Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN . Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008; 68: 1012–1021.
Lia M, Carette A, Tang H, Shen Q, Mo T, Bhagat G et al. In Vivo functional dissection of the chromosome 13q14 tumor suppressor locus reveals that extent of deletions impacts disease course and phenotype. Blood 2011; 118: 468.
Hammarsund M, Corcoran MM, Wilson W, Zhu C, Einhorn S, Sangfelt O et al. Characterization of a novel B-CLL candidate gene--DLEU7--located in the 13q14 tumor suppressor locus. FEBS Lett 2004; 556: 75–80.
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463: 899–905.
Crowther-Swanepoel D, Broderick P, Ma Y, Robertson L, Pittman AM, Price A et al. Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum Mol Genet 2010; 19: 1840–1845.
Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008; 40: 1204–1210.
Havelange V, Pekarsky Y, Nakamura T, Palamarchuk A, Alder H, Rassenti L et al. IRF4 mutations in chronic lymphocytic leukemia. Blood 2011; 118: 2827–2829.
Michaux L, Wlodarska I, Rack K, Stul M, Criel A, Maerevoet M et al. Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL. Leukemia 2005; 19: 77–82.
Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997; 275: 540–543.
Acknowledgements
We would like to thank the families and patients who participated in this study as well as the clinic and research staff who assist with sample collection. We thank the Broad Institute of Harvard and MIT for running the SNP arrays, and the DFCI Microarray core facility for gene expression profiling. YEW and MC are supported through the CCCB and the Dana-Farber Strategic Plan Initiative. CJW acknowledges support from the Leukemia and Lymphoma Translational Research Program and is a Damon-Runyon Clinical Investigator supported in part by the Damon-Runyon Cancer Research Foundation (CI-38-07). NP is a postdoctoral research fellow of the Fund for Scientific Research-Flanders (FWO Vlaanderen) and a Broad Fellow of the Broad Institute. AR is supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, an NIH Pioneer award, HHMI and the Merkin Foundation for Stem Cell Research at the Broad Institute. ASF is supported in part by NIH 5 PO1 CA092625. JRB is supported by K23 CA115682 from the National Institutes of Health and is a Scholar of the American Society of Hematology as well as a Scholar in Clinical Research of the Leukemia and Lymphoma Society. These studies were supported by the Okonow-Lipton Fund, the Melton Fund and the Rosenbach Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Brown, J., Hanna, M., Tesar, B. et al. Germline copy number variation associated with Mendelian inheritance of CLL in two families. Leukemia 26, 1710–1713 (2012). https://doi.org/10.1038/leu.2012.33
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.33